Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Linezolid in the Treatment of Subjects With Complicated Skin and Soft Tissue Infections Proven to be Due to Methicillin-Resistant Staphylococcus Aureus

NCT00087490 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00087490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00087490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Linezolid in the Treatment of Subjects With Complicated Skin and Soft Tissue Infections Proven to be Due to Methicillin-Resistant Staphylococcus Aureus
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2004
Completion date
July 31, 2007
Enrollment
1,077 (actual)
Sites
126

Conditions

As the registry lists them; a condition with its own page is linked.

methicillin resistant staphylococcus aureus (mrsa), skin/soft tissue infections